Researchers in Prof. Hongjie Dai's laboratory have combined graphene with metals and other inorganic elements to create a variety of hybrid materials that can be used for high performance electrocatalytic or electrochemical devices such as batteries and fuel cells.
Stanford researchers have discovered a novel scheme of treatment planning and delivery of radiation therapy, termed station parameter optimized radiation therapy, or SPORT.
Researchers in Prof. Hongjie Dai's laboratory have developed nanocarbon/inorganic nanoparticle hybrid materials for various electrocatalytic and electrochemical applications, such as batteries and fuel cells. Three types of hybrid materials have been created:
Researchers in Prof. Monte Winslow's laboratory have developed two viable, fertile transgenic mouse strains that enable rapid, simple generation of loss-of-function models with CRISPR/Cas9 mediated genome editing in vivo or ex vivo.
Stanford researchers have patented a photosynthetic system using a cyanobacterium solution that can be delivered to ischemic tissues, where blood flow is insufficient. This addresses a major clinical problem for patients with heart and vascular diseases.
Researchers at Stanford have developed a mouse model of psoriasis that closely mimics human psoriasis. Psoriasis is a chronic inflammatory disorder characterized by itchy, disfiguring skin lesions.
Stanford researcher Paul Norman has developed an integrated capture/next-gen sequencing/ bioinformatics method to completely characterize the structure and sequence of the highly polymorphic killer cell immunoglobulin-like receptor (KIR) genes to aid in donor matching for clin
Stanford researchers have proposed a new concept for direct measurement of specific absorption ratio (SAR), to be used as a safety assessment / monitoring tool for magnetic resonance imaging (MRI).
ChiRP (“Chromatin Isolation through RNA Purification”) is a patented RNA “interactomics” technique developed in Prof. Howard Chang's laboratory to capture and identify DNA, RNA or protein molecules that interact with any RNA of interest in a cell.
Researchers in Prof. Mark Kay's laboratory have continued to develop novel recombinant adeno-associated viral (AAV) capsids via capsid gene shuffling that transduce human hepatocytes at high efficiency in vivo.
The standard treatment for hepatitis C virus (HCV) is poorly tolerated and ineffective in a large subset of HCV patients. Scientists at Stanford and UCSF have developed new therapeutic leads for HCV that also have potential to be broad-spectrum anti-infectives.
Stanford researchers have patented an image sensor that overcomes frame rate and power consumption limits for high-speed mega-pixel imaging, and therefore can extend battery life for mobile phone cameras.
A team of Stanford engineers have developed a fast adaptive optics system for scanning, 3D imaging and sensing with a small (50 µm) multimode fiber (MMF).
Researchers in Prof. James Swartz' laboratory have developed a rapid bioluminescence method for detecting and enumerating circulating tumor cells (CTCs) and other rare cells. This invention utilizes novel nanoparticle reagents which can specifically bind to cells of interest.